NasdaqGS - Nasdaq Real Time Price • USD
CG Oncology, Inc. (CGON)
At close: 4:00 PM EDT
After hours: 4:53 PM EDT
Major Holders
| Breakdown | |
|---|---|
| 7.05% | % of Shares Held by All Insider |
| 50.21% | % of Shares Held by Institutions |
| 54.01% | % of Float Held by Institutions |
| 71 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Blackrock Inc. | 2.52M | Mar 31, 2024 | 3.78% | 68,806,785 |
| Vanguard Group Inc | 2.23M | Mar 31, 2024 | 3.34% | 60,787,491 |
| Franklin Resources, Inc. | 848.09k | Mar 31, 2024 | 1.27% | 23,169,873 |
| Geode Capital Management, LLC | 504.22k | Mar 31, 2024 | 0.76% | 13,775,180 |
| American International Group, Inc. | 306.23k | Mar 31, 2024 | 0.46% | 8,366,094 |
| Times Square Capital Management, LLC | 224.07k | Mar 31, 2024 | 0.34% | 6,121,674 |
| Charles Schwab Investment Management, Inc. | 169.35k | Mar 31, 2024 | 0.25% | 4,626,696 |
| Bank Of New York Mellon Corporation | 64.54k | Mar 31, 2024 | 0.10% | 1,763,314 |
| Nuveen Asset Management, LLC | 61.87k | Mar 31, 2024 | 0.09% | 1,690,179 |
| Rhumbline Advisers | 30.29k | Mar 31, 2024 | 0.05% | 827,495 |
Top Mutual Fund Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| iShares Russell 2000 ETF | 568.67k | Mar 31, 2024 | 0.85% | 15,536,200 |
| AB Cap Fd.-AB Small Cap Growth Port | 517.44k | Mar 31, 2024 | 0.78% | 14,136,460 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 297.01k | Feb 29, 2024 | 0.45% | 8,114,231 |
| Franklin Strategic Series-Franklin Small-Mid Cap Growth | 287.6k | Jan 31, 2024 | 0.43% | 7,857,231 |
| Franklin Strategic Series-Franklin Small Cap Growth Fund | 197.8k | Jan 31, 2024 | 0.30% | 5,403,895 |
| MFS New Discovery Fund | 171.1k | Feb 29, 2024 | 0.26% | 4,674,479 |
| Principal Small Cap Growth Fd I | 120.05k | Jan 31, 2024 | 0.18% | 3,279,847 |
| iShares Russell 2000 Value ETF | 121.29k | Mar 31, 2024 | 0.18% | 3,313,642 |
| Fidelity Extended Market Index Fund | 116.3k | Mar 31, 2024 | 0.17% | 3,177,206 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 101.6k | Jan 31, 2024 | 0.15% | 2,775,711 |
Related Tickers
KYTX Kyverna Therapeutics, Inc.
15.50
+5.95%
ANRO Alto Neuroscience, Inc.
14.16
+0.50%
GPCR Structure Therapeutics Inc.
35.70
-0.81%
SLRN Acelyrin, Inc.
4.7300
+0.85%
AVBP ArriVent BioPharma, Inc.
18.46
+2.96%
CABA Cabaletta Bio, Inc.
11.23
-0.27%
RYTM Rhythm Pharmaceuticals, Inc.
40.38
+0.45%
MGX Metagenomi, Inc.
6.54
-0.15%
APGE Apogee Therapeutics, Inc.
54.00
+2.41%
JANX Janux Therapeutics, Inc.
47.91
-4.16%